Homepage
Medication Guide
Adverse Effects of Canakinumab (Ilaris)
Canakinumab (Ilaris) is a monoclonal antibody drug indicated for the treatment of various autoinflammatory diseases, exerting its therapeutic effects by inhibiting interleukin-1β (IL-1β). Despite its ...
503
Tuesday, January 20th, 2026, 09:49
What are the Precautions for Canakinumab (Ilaris) Administration?
Canakinumab (Ilaris) is a humanized monoclonal antibody that exerts its therapeutic effect by specifically blocking the activity of interleukin-1β (IL-1β), and is primarily indicated for the treatment...
506
Tuesday, January 20th, 2026, 09:47
Dosage and Administration, Recommended Doses of Canakinumab (Ilaris)
Canakinumab (Ilaris) is a fully human monoclonal antibody that neutralizes interleukin-1β (IL-1β) with high affinity and selectivity, thereby inhibiting its key role in various autoinflammatory diseas...
504
Tuesday, January 20th, 2026, 09:45
What are the Indications for Canakinumab (Ilaris)?
Canakinumab (Ilaris) is a recombinant humanized monoclonal antibody indicated for the treatment of various autoinflammatory diseases. It exerts its therapeutic effect by specifically neutralizing the ...
506
Tuesday, January 20th, 2026, 09:42
What Are the Purchase Channels for Canakinumab (Ilaris)?
Canakinumab (Ilaris) is a biological agent indicated for the treatment of various inflammatory diseases. Its purchase channels and precautions are of great significance for patients.What Are the Purch...
508
Monday, January 19th, 2026, 14:47
Adverse Reactions of Trabectedin (Yondelis)
Trabectedin (Yondelis) is an alkylating agent indicated for the treatment of unresectable or metastatic liposarcoma or leiomyosarcoma in patients who have received prior anthracycline-containing regim...
503
Monday, January 19th, 2026, 14:44
What are the Precautions for Using Trabectedin (Yondelis)?
Trabectedin (Yondelis) is an alkylating antineoplastic agent indicated for the treatment of specific soft tissue sarcomas. It is used in patients with unresectable or metastatic liposarcoma or leiomyo...
505
Monday, January 19th, 2026, 14:27
Dosage and Administration, Recommended Dose of Trabectedin (Yondelis)
Trabectedin (Yondelis) is an alkylating agent indicated for the treatment of specific types of soft tissue sarcoma. It is used in adult patients with unresectable or metastatic liposarcoma or leiomyos...
506
Monday, January 19th, 2026, 14:24
What are the Indications for Trabectedin (Yondelis)?
Trabectedin (Yondelis) is an injectable alkylating agent indicated for the treatment of specific types of soft tissue sarcoma. First approved for marketing in the United States in 2015, this medicatio...
507
Monday, January 19th, 2026, 14:21
What Are the Purchase Channels for Trabectedin (Yondelis)?
Trabectedin (Yondelis) is a prescription medication indicated for the treatment of specific types of soft tissue sarcomas (e.g., liposarcoma and leiomyosarcoma) in patients who have previously receive...
503
Friday, January 16th, 2026, 09:34
13 / 206
2051 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved